Global Personalized Medicine Market Report 2024

Personalized Medicine Global Market Report 2024 – By Product (Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness), By Application (Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications), By End-use (Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Personalized Medicine Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Personalized Medicine Global Market Report 2023

Proud Members Of

checkslacipN checkaoirsN checkscipN

Personalized Medicine Market Definition

Personalized medicine is tailoring medical treatment to an individual's specific genetic, environmental, and lifestyle factors by considering an individual's unique characteristics to help prevent, diagnose, and treat disease. It seeks to deliver the correct therapies to the right patients at the right time.

The main products of personalized medicine are personalized medicine diagnostics, personalized medicine therapeutics, personalized medical care, and personalized nutrition and wellness. Personalized medicine diagnostics refers to studying an individual's specific genetic, molecular, and clinical characteristics to guide the diagnosis, treatment, and management of their disease. It is used in disease diagnosis, treatment selection, monitoring treatment response, and clinical trial selection. The various applications of personalized medicine include oncology, neurology, blood transfusion safety, diabetes, autoimmune diseases, cardiology, and others that are used in hospitals, diagnostic centers, research and academic institutes, and others.

Personalized Medicine Market Segmentation

The personalized medicine market covered in this report is segmented –

1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness

2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications

3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users

Global Personalized Medicine Market Size 2023 to 2028: Graph

Personalized Medicine Market Size 2024 And Growth Rate

The personalized medicine market size has grown rapidly in recent years. It will grow from $352.73 billion in 2023 to $390.65 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to rise of companion diagnostics, patient-centric healthcare, drug development paradigm shift, healthcare cost containment, increasing prevalence of chronic diseases.

Personalized Medicine Market Growth Forecast

The personalized medicine market size is expected to see rapid growth in the next few years. It will grow to $590.51 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to continued genomic advancements, expansion of biomarker discovery, growing adoption of telemedicine, regulatory support and frameworks, collaboration and data sharing. Major trends in the forecast period include integration of artificial intelligence (AI), advancements in genomic sequencing, data integration and analytics, immunotherapy and targeted therapies, patient empowerment and informed decision-making, collaborations and partnerships.

Personalized Medicine Market Driver: Rare Diseases Drive Personalized Medicine Growth

The increasing prevalence of rare diseases is expected to propel the growth of the personalized medicine market going forward. The increasing prevalence of rare diseases refers to the growing number of people who are diagnosed with rare diseases such as Klinefelter Syndrome, Aarskog Syndrome, Abetalipoproteinemia, and others. Personalized medicine approaches help to provide more tailored treatment options for individuals with rare diseases which are on the rise. For instance, in March 2021, according to the Journal of the European Academy of Dermatology and Venereology, the population prevalence of rare diseases was estimated at 3.5%-5.9%. this is equal to 260-440 million individuals affected across the world at a time. Moreover, according to an article published by Global Genes, a US-based non-profit advocacy organization, Globally 400 million people are suffering from a rare disease. Therefore, the increase in the prevalence of rare diseases is driving the growth of the personalized medicine market.

Personalized Medicine Market Driver: Impact Of Obesity On Personalized Medicine Growth

The growing obese population is expected to propel the growth of the personalized medicine market going forward. Obesity refers to the abnormal or excessive accumulation of fat, which might impair the health of individuals. The personalized medicine is used in addressing the specific genetic and molecular factors contributing to obesity, thereby offering tailored and effective interventions for individuals. For instance, in March 2022, according to the World Health Organization (WHO), over 1 billion people globally are currently obese (2022), of whom 650 million are adults, 340 million are adolescents, and 39 million are children. By 2025, around 167 million people adults and children will become less healthy as they are overweight or obese. Therefore, the growing obese population is driving the growth of the personalized medicine market.

Global Personalized Medicine Market Major Players

Major companies operating in the personalized medicine market report are Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Guardiome, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc.

Global Personalized Medicine Market Trend: Technology Adoption By Major Companies In Personalized Medicine

Technological advancements are a key trend gaining popularity in the personalized medicine market. Major companies operating in the personalized medicine market are adopting new technologies to sustain their position in the market. For instance, in April 2023, OM1, a US-based healthcare company that utilizes real-world data and artificial intelligence (AI) to assist healthcare providers, patented an AI-powered platform to accelerate personalized medicine. This technology employs large-scale data analysis to generate meaningful insights into diagnoses, progression, and treatment responses. Its significance lies in offering tailored healthcare inputs, enhancing informed decision-making for healthcare providers, and expediting clinical trials by identifying suitable candidates efficiently, contributing to the advancement of personalized medicine in the market.

Global Personalized Medicine Market Trend: Advancing Precision Medicine In Mental Health Through Real-World Data Programs And AI Integration

Major companies operating in the personalized medicine market are focusing on product launches, such as real-world data programs aimed at powering precision medicine solutions using real-world data for mental health. A real-world data program involves the systematic collection and analysis of information from everyday clinical practice and patient experiences to inform healthcare decisions and outcomes. For instance, in May 2022, Tempus, a US-based technology company that uses artificial intelligence to advance precision medicine, launched Tempus N+, a psychiatric real-world data program. The features include collaboration with academic medical institutions, an integrated operating system for mental health, secure data pipelines, access to real-world data, and an expansion of psychiatric care through EMR integration and pharmacogenomic testing. This launch significantly contributes to the personalized medicine market by advancing precision medicine solutions for mental health, utilizing real-world data, artificial intelligence, and academic collaborations to enhance treatment plans, improve patient outcomes, and empower data-driven decisions in mental health care.

Personalized Medicine Market Merger And Acquisition:

4D Molecular Therapeutics Acquires Worldwide Rights To Scfh From Aevitas Therapeutics

In April 2023, 4D Molecular Therapeutics (4DMT), a US-based clinical-stage gene therapy company developing products to treat rare and prevalent diseases, acquired all world-wide rights to short-form human complement factor H (sCFH) from Aevitas Therapeutics, Inc. for $140 million. This acquisition signifies a significant advancement in personalized medicine for rare and genetic diseases, especially in treating geographic atrophy, by targeting the complement pathway and offering potential improvements in patient outcomes. Aevitas Therapeutics, Inc., also US-based, is a biopharmaceutical company focused on developing and commercializing gene therapies for complement-mediated diseases.

Regional Insights For The Global Personalized Medicine Market

North America was the largest region in the personalized medicine market in 2023. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the personalized medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The personalized medicine market consists of sales of topical creams, serums, dietary supplements, customized meal plans, nutritional products, and drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The personalized medicine market research report is one of a series of new reports from The Business Research Company that provides personalized medicine market statistics, including personalized medicine industry global market size, regional shares, competitors with a personalized medicine market share, detailed personalized medicine market segments, market trends and opportunities, and any further data you may need to thrive in the personalized medicine industry. This personalized medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Personalized Medicine Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $390.65 billion
Revenue Forecast In 2033 $590.51 billion
Growth Rate CAGR of 10.9% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness
2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications
3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-Users
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Bayer AG; Novartis AG; Thermo Fisher Scientific Inc.; GlaxoSmithKline plc; AstraZeneca plc; Abbott Laboratories; Danaher Corporation; Eli Lilly and Company; Decode Genetics Inc.; GE HealthCare Technologies Inc.; Roche Diagnostics; Genentech Inc.; Biogen Inc.; Illumina Inc.; Qiagen N.V.; Exact Sciences Corporation; Myriad Genetics Inc.; Verily Life Sciences LLC; Guardant Health Inc.; Tempus Labs; Oxford Nanopore Technologies; Foundation Medicine Inc.; NanoString Technologies Inc.; Exagen Inc.; Asuragen Inc.; Personal Genome Diagnostics; Precision Biologics Inc.; Strata Oncology; Genelex Corp.; Guardiome; Invitae Corporation; Color Genomics; Helix OpCo LLC; 10x Genomics Inc.; Agena Bioscience Inc.; Natera Inc.; Becton Dickinson and Company; PerkinElmer Inc.; Sophia Genetics; Genomic Vision; Personalis Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Personalized Medicine Market Characteristics

    3. Personalized Medicine Market Trends And Strategies

    4. Personalized Medicine Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Personalized Medicine Market Size and Growth

    5.1. Global Personalized Medicine Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Personalized Medicine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Personalized Medicine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Personalized Medicine Market Segmentation

    6.1. Global Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Personalized Medicine Diagnostics

    Personalized Medicine Therapeutics

    Personalized Medical Care

    Personalized Nutrition and Wellness

    6.2. Global Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Oncology

    Neurology

    Blood Transfusion Safety

    Diabetes

    Autoimmune Diseases

    Cardiology

    Other Applications

    6.3. Global Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals

    Diagnostic Centers

    Research and Academic Institutes

    Other End-Users

    7. Personalized Medicine Market Regional And Country Analysis

    7.1. Global Personalized Medicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Personalized Medicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Personalized Medicine Market

    8.1. Asia-Pacific Personalized Medicine Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Personalized Medicine Market

    9.1. China Personalized Medicine Market Overview

    9.2. China Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Personalized Medicine Market

    10.1. India Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Personalized Medicine Market

    11.1. Japan Personalized Medicine Market Overview

    11.2. Japan Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Personalized Medicine Market

    12.1. Australia Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Personalized Medicine Market

    13.1. Indonesia Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Personalized Medicine Market

    14.1. South Korea Personalized Medicine Market Overview

    14.2. South Korea Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Personalized Medicine Market

    15.1. Western Europe Personalized Medicine Market Overview

    15.2. Western Europe Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Personalized Medicine Market

    16.1. UK Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Personalized Medicine Market

    17.1. Germany Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Personalized Medicine Market

    18.1. France Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Personalized Medicine Market

    19.1. Italy Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Personalized Medicine Market

    20.1. Spain Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Personalized Medicine Market

    21.1. Eastern Europe Personalized Medicine Market Overview

    21.2. Eastern Europe Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Personalized Medicine Market

    22.1. Russia Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Personalized Medicine Market

    23.1. North America Personalized Medicine Market Overview

    23.2. North America Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Personalized Medicine Market

    24.1. USA Personalized Medicine Market Overview

    24.2. USA Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Personalized Medicine Market

    25.1. Canada Personalized Medicine Market Overview

    25.2. Canada Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Personalized Medicine Market

    26.1. South America Personalized Medicine Market Overview

    26.2. South America Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Personalized Medicine Market

    27.1. Brazil Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Personalized Medicine Market

    28.1. Middle East Personalized Medicine Market Overview

    28.2. Middle East Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Personalized Medicine Market

    29.1. Africa Personalized Medicine Market Overview

    29.2. Africa Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Personalized Medicine Market Competitive Landscape And Company Profiles

    30.1. Personalized Medicine Market Competitive Landscape

    30.2. Personalized Medicine Market Company Profiles

    30.2.1. Bayer AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Novartis AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Thermo Fisher Scientific Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. GlaxoSmithKline plc

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. AstraZeneca plc

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Personalized Medicine Market Other Major And Innovative Companies

    31.1. Abbott Laboratories

    31.2. Danaher Corporation

    31.3. Eli Lilly and Company

    31.4. Decode Genetics Inc.

    31.5. GE HealthCare Technologies Inc.

    31.6. Roche Diagnostics

    31.7. Genentech Inc.

    31.8. Biogen Inc.

    31.9. Illumina Inc.

    31.10. Qiagen N.V.

    31.11. Exact Sciences Corporation

    31.12. Myriad Genetics Inc.

    31.13. Verily Life Sciences LLC

    31.14. Guardant Health Inc.

    31.15. Tempus Labs

    32. Global Personalized Medicine Market Competitive Benchmarking

    33. Global Personalized Medicine Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Personalized Medicine Market

    35. Personalized Medicine Market Future Outlook and Potential Analysis

    35.1 Personalized Medicine Market In 2028 - Countries Offering Most New Opportunities

    35.2 Personalized Medicine Market In 2028 - Segments Offering Most New Opportunities

    35.3 Personalized Medicine Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Personalized Medicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Personalized Medicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Bayer AG Financial Performance
  • Table 75: Novartis AG Financial Performance
  • Table 76: Thermo Fisher Scientific Inc. Financial Performance
  • Table 77: GlaxoSmithKline plc Financial Performance
  • Table 78: AstraZeneca plc Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Personalized Medicine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Personalized Medicine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Personalized Medicine Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Personalized Medicine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Personalized Medicine Market, Segmentation By End-use, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Bayer AG Financial Performance
  • Figure 75: Novartis AG Financial Performance
  • Figure 76: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 77: GlaxoSmithKline plc Financial Performance
  • Figure 78: AstraZeneca plc Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the personalized medicine market?

Personalized medicine is tailoring medical treatment to an individual's specific genetic, environmental, and lifestyle factors by considering an individual's unique characteristics to help prevent, diagnose, and treat disease. It seeks to deliver the correct therapies to the right patients at the right time. For further insights on the personalized medicine market, request a sample here

How will the personalized medicine market drivers and restraints affect the personalized medicine market dynamics? What forces will shape the personalized medicine industry going forward?

The personalized medicine market major growth driver - rare diseases drive personalized medicine growth. For further insights on the personalized medicine market, request a sample here

What is the forecast market size or the forecast market value of the personalized medicine market ?

The personalized medicine market size has grown rapidly in recent years. It will grow from $352.73 billion in 2023 to $390.65 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to rise of companion diagnostics, patient-centric healthcare, drug development paradigm shift, healthcare cost containment, increasing prevalence of chronic diseases. The personalized medicine market size is expected to see rapid growth in the next few years. It will grow to $590.51 billion in 2028 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to continued genomic advancements, expansion of biomarker discovery, growing adoption of telemedicine, regulatory support and frameworks, collaboration and data sharing. Major trends in the forecast period include integration of artificial intelligence (AI), advancements in genomic sequencing, data integration and analytics, immunotherapy and targeted therapies, patient empowerment and informed decision-making, collaborations and partnerships. For further insights on the personalized medicine market, request a sample here

How is the personalized medicine market segmented?

The personalized medicine market is segmented
1) By Product: Personalized Medicine Diagnostics, Personalized Medicine Therapeutics, Personalized Medical Care, Personalized Nutrition and Wellness
2) By Application: Oncology, Neurology, Blood Transfusion Safety, Diabetes, Autoimmune Diseases, Cardiology, Other Applications
3) By End-use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Other End-UsersFor further insights on the personalized medicine market,
request a sample here

Which region has the largest share of the personalized medicine market? What are the other regions covered in the report?

North America was the largest region in the personalized medicine market in 2023. Asia-pacific is expected to be the fastest-growing region in the global personalized medicine market during the forecast period. The regions covered in the personalized medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the personalized medicine market, request a sample here.

Who are the major players in the personalized medicine market?

Major companies operating in the personalized medicine market report are Bayer AG, Novartis AG, Thermo Fisher Scientific Inc., GlaxoSmithKline plc, AstraZeneca plc, Abbott Laboratories, Danaher Corporation, Eli Lilly and Company, Decode Genetics Inc., GE HealthCare Technologies Inc., Roche Diagnostics, Genentech Inc., Biogen Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Myriad Genetics Inc., Verily Life Sciences LLC, Guardant Health Inc., Tempus Labs, Oxford Nanopore Technologies, Foundation Medicine Inc., NanoString Technologies Inc., Exagen Inc., Asuragen Inc., Personal Genome Diagnostics, Precision Biologics Inc., Strata Oncology, Genelex Corp, Guardiome, Invitae Corporation, Color Genomics, Helix OpCo LLC, 10x Genomics Inc., Agena Bioscience Inc., Natera Inc., Becton Dickinson and Company, PerkinElmer Inc., Sophia Genetics, Genomic Vision, Personalis Inc. For further insights on the personalized medicine market, request a sample here.

What are the key trends in the personalized medicine market?

Major trend in the personalized medicine market - advancing precision medicine in mental health through real-world data programs and ai integration. For further insights on the personalized medicine market, request a sample here.

What are the major opportunities in the personalized medicine market? What are the strategies for the personalized medicine market?

For detailed insights on the major opportunities and strategies in the personalized medicine market, request a sample here.

How does the personalized medicine market relate to the overall economy and other similar markets?

For detailed insights on personalized medicine market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the personalized medicine industry?

For detailed insights on the mergers and acquisitions in the personalized medicine industry, request a sample here.

What are the key dynamics influencing the personalized medicine market growth? SWOT analysis of the personalized medicine market.

For detailed insights on the key dynamics influencing the personalized medicine market growth and SWOT analysis of the personalized medicine industry, request a sample here.